John Temperato, Chief Executive Officer at 9 METERS BIOPHARMA, INC. (NMTR), bought 35,000 shares at $0.57 ($20K) on 2020-08-17, disclosed to the SEC on 2020-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NMTR | BUY | 2022-03-04 | $112K | — | Filing → |
| NMTR | BUY | 2021-11-19 | $53K | — | Filing → |
| NMTR | BUY | 2021-08-19 | $26K | — | Filing → |